NCT02452008 2025-12-19Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Active not recruiting60 enrolled